» Articles » PMID: 35930203

Multi-level Factors Driving Pre-exposure Prophylaxis Non-initiation Among Young Women at High Risk for HIV in Kenya

Abstract

Few studies have focused on understanding pre-exposure prophylaxis (PrEP) non-initiation among young, high-risk women in sub-Saharan Africa. This study aimed to qualitatively explore why young women in Kenya at high-risk for HIV chose not to enroll in a PrEP adherence trial. We performed 40 semi-structured interviews with young high-risk women assessing concerns about PrEP and/or study participation. We also assessed community-level factors influencing decision-making around PrEP through 10 focus groups involving peers, young men, caregivers, and community leaders. Our qualitative data reflect the complexity of navigating barriers preventing PrEP initiation in settings where taking PrEP may be perceived as immoral behavior. Framed within the context of risk perception, the decision to start PrEP may run counter to the potential risk of losing support from one's community. Our findings suggest that approaches addressing social norms, while de-medicalizing HIV prevention services, are needed to further increase PrEP uptake among young Kenyan women.

Citing Articles

Measuring the uptake of clinic-based HIV treatment and prevention services following HIV testing and referral at private pharmacies in Kenya.

Omollo V, Roche S, Zhang S, Asewe M, Rono B, Kwach B BMC Health Serv Res. 2025; 25(1):23.

PMID: 39755595 PMC: 11699675. DOI: 10.1186/s12913-024-12165-8.


Formalized peer referral to HIV pre-exposure prophylaxis supported with self-testing: a mixed-methods pilot study among young Kenyan women.

McGowan M, Wairimu N, Reedy A, Mogere P, Culquichicon C, Njeru I Front Public Health. 2024; 12:1428609.

PMID: 39324163 PMC: 11422135. DOI: 10.3389/fpubh.2024.1428609.


"Emotional stress is more detrimental than the virus itself": A qualitative study to understand HIV testing and pre-exposure prophylaxis (PrEP) use among internal migrant men in South Africa.

Nardell M, Govathson-Mandimika C, Garnier S, Watts A, Babalola D, Ngcobo N J Int AIDS Soc. 2024; 27(3):e26225.

PMID: 38462755 PMC: 10935710. DOI: 10.1002/jia2.26225.